ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Clanton Resigns From NCI.

January 12, 2007

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

In Brief: Sporn Wins BMS Cancer Research Award; Dana-Farber To Try To Affect Teen Health

April 3, 1998

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014